Clinical trials
Diabetes clinical trials
Below are recruiting diabetes clinical trials, each written for real people, not researchers. We’re tracking 2,208 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06738849Recruiting
Testing an app for insulin dosing
This trial tests the EkiYou smartphone app to help calculate your mealtime insulin dose. You need to have diabetes, use both a long-acting and a short-acting insulin pen, and be comfortable with a CGM and a smartphone.
BobignyAges 18 years+ - NCT06745544Recruiting
Exercise program to prevent falls in older adults with diabetes
This trial tests whether a special exercise program (with music and multitasking) can help reduce falls and fractures and improve heart health in older adults with diabetes. If you are 65+ and have diabetes, you may be able to join and get free exercise classes.
Aalborg, NorhAges 65 years+ - NCT06778005Recruiting
Ultrasound of leg nerves in type 2 diabetes with nerve damage
This study uses ultrasound (an imaging test) to measure the nerves in the legs of people with type 2 diabetes who have nerve damage. It helps doctors learn more about how diabetes affects nerves.
Istanbul, ÜsküdarAges 18–65 - NCT06826703Recruiting
Motivational interviewing for diabetes self-management and cyberchondria
This study tests whether talking with a coach (motivational interviewing) helps people with diabetes better manage their condition and reduces worry caused by looking up health information online (cyberchondria).
Van, VanAges 18 years+ - NCT06837103Recruiting
Continuous glucose monitor and coaching for type 2 diabetes
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
Toronto, OntarioAges 18 years+ - NCT06844539Recruiting
Helping beta cells to reverse type 2 diabetes
This study tests whether a treatment can help your pancreas make more insulin and possibly put your type 2 diabetes into remission. It is for people diagnosed with type 2 diabetes in the last 5 years who are already on diabetes medication.
Cambridge, CambridgeshireAges 18 years+ - NCT06848244Recruiting
Preventing diabetes in young Black women
This trial tests a program to help young Black women with prediabetes and binge eating prevent type 2 diabetes using a smartphone. It focuses on healthy eating and behavior change.
Chapel Hill, North CarolinaAges 18–25 - NCT06852950Recruiting
CGM for diabetes management after hospital discharge
This trial tests if using a continuous glucose monitor (CGM) after leaving the hospital helps manage diabetes. You wear a small sensor on your arm that checks your sugar levels all day and sends them to your phone.
Nashville, TennesseeAges 18 years+ - NCT06887049Recruiting
Screening for emotional health in type 2 diabetes
This study tests a program to regularly screen and support emotional health in adults with type 2 diabetes and high blood sugar (A1C greater than 8%). It aims to improve both emotional well-being and diabetes management.
Chicago, IllinoisAges 18 years+ - NCT06894784RecruitingPhase 3
Combining two diabetes drugs with an automated insulin pump
This trial tests if adding semaglutide and empagliflozin to your automated insulin delivery system (like a smart pump) can improve blood sugar control for adults with type 1 diabetes. It may help with both glucose levels and weight management.
Montreal, QuebecAges 18 years+ - NCT06902077Recruiting
Low-carb diet for teens with type 2 diabetes
This trial tests if a low-carb diet helps teens with type 2 diabetes manage their blood sugar. It may lead to better control without needing insulin.
Birmingham, AlabamaAges 12–18 - NCT06902597Recruiting
Sarcopenia and nerve damage in type 1 diabetes: a pilot study
This study looks at whether muscle loss (sarcopenia) is related to diabetic nerve damage in adults with type 1 diabetes. If you join, you will help researchers understand this connection better.
Rome, LazioAges 50–80 - NCT06906081RecruitingPhase 2
Finerenone for diabetic nerve damage (FibroCAN study)
This trial tests if finerenone can help people with type 2 diabetes who have early signs of nerve damage affecting their heart and blood vessels (cardiovascular autonomic neuropathy). It aims to see if the drug can improve heart rate control and reduce symptoms.
GistrupAges 40 years+ - NCT06916663Recruiting
Upper body vs. combined exercise during diabetic foot ulcer treatment
This trial compares two exercise programs for people with diabetic foot ulcers: one that uses only upper body exercises and one that combines upper body with non-weight bearing lower body exercises. The goal is to see which approach helps healing while keeping weight off the foot.
CairoAges 18–65 - NCT06919029Recruiting
New insulin pump study for children with new type 1 diabetes
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
AthensAges 7–17 - NCT06945406RecruitingPhase 1
Study of an investigational drug for diabetes
This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.
NeussAges 18 years+ - NCT06957093Recruiting
AI‐assisted diabetes care vs standard management
This study tests whether an AI‐powered digital health platform can help people with type 2 diabetes better manage their blood sugar. If you use a smartphone and have had diabetes for at least a year, this may be a convenient way to receive extra support.
Changchun, JilinAges 18–75 - NCT06958302Recruiting
Diabetes Nerve Damage and Muscle Mass in Type 2 Diabetes
This study examines how nerve damage from diabetes (diabetic neuropathy) relates to muscle loss in people with type 2 diabetes. It aims to help understand and possibly prevent muscle weakness.
Cairo, AbbassiaAges 45 years+ - NCT06966427Recruiting
Using a dosing app for insulin management
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
Petah TikvaAges 6–75 - NCT06968611Recruiting
Diabetes and vision care study in Bangladesh
This study tests a program that combines diabetes care with eye exams for people in Bangladesh who were recently diagnosed with diabetes. The goal is to see if this approach helps you better manage your health and prevent vision problems.
DinajpurAges 30 years+ - NCT06968637Recruiting
Improving diabetes and vision care in Bangladesh
This study tests a new way to combine diabetes care with eye care for people with diabetes in Bangladesh. If you have diabetes and a diabetes-related eye condition, this might help improve your care.
Dinajpur Sadar, DinajpurAges 30 years+ - NCT06976619RecruitingPhase 2
Blood sugar control and a diabetes drug on insulin production
This study looks at how blood sugar control and a class of drugs called GLP-1 agonists (like Ozempic) affect insulin-making cells in people with type 1 or type 2 diabetes who use insulin.
Rochester, MinnesotaAges 25–70 - NCT06976658RecruitingPhase 2
Glucokinase Activator for GCK-MODY Diabetes
This trial tests an experimental pill (a glucokinase activator) in adults with a specific genetic form of diabetes called GCK-MODY. The study aims to see if the pill can help control blood sugar without causing dangerously low sugar levels.
Hong KongAges 18–74 - NCT06984822Recruiting
Comparing eye injections for diabetic macular edema
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
MölndalAges 18 years+
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes?
- Yes. Clin2 currently lists 2,208 recruiting diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.